Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Caplin, Martyn E

Lanreotide in metastatic enteropancreatic neuroendocrine tumors. [electronic resource] - The New England journal of medicine Jul 2014 - 224-33 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1316158 doi


Aged
Antineoplastic Agents--adverse effects
Delayed-Action Preparations
Diarrhea--etiology
Disease-Free Survival
Double-Blind Method
Female
Gastrointestinal Neoplasms--drug therapy
Humans
Male
Middle Aged
Neuroendocrine Tumors--drug therapy
Pancreatic Neoplasms--drug therapy
Peptides, Cyclic--adverse effects
Somatostatin--adverse effects